EFFICACY OF EPINEPHRINE VERSUS NOR-EPINEPHRINE AS THE INITIAL VASOACTIVE AGENT IN PAEDIATRIC SEPTIC SHOCK- A RANDOMIZED CONTROLLED TRIAL,EPINESS STUDY - EPINESS TRIA

Apollo Hospital Chennai0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月30日

试验速览

暂无简介。

•All children aged 1 month to 17 years with early septic shock- suspect or confirmed sepsis and unresolved shock/hypoperfusion after initial 10-20ml/kg of fluid bolus

•1.Children with fulminant myocarditis
•2.Children with unrepaired congenital heart disease
•3.Post-operative sepsis/septic shock within 48 hours of bypass surgery.
•4.Children with Severe Acute Malnutrition
•5.Children with chronic kidney disease.
•6.Parents not willing to participate in the study
•7.Caregiver/Physician unwilling for patient to be enrolled
•8.Post-arrest shock and cardiac dysfunction
•9.Moribund patients in whom anticipated survival < 24 hrs (since many are in are in recalcitrant downward spiral of overall condition where the impact of one or other vasoactive may be difficult to assess).

发起方

Apollo Hospital Chennai